全文获取类型
收费全文 | 15409篇 |
免费 | 1208篇 |
国内免费 | 1889篇 |
专业分类
18506篇 |
出版年
2024年 | 36篇 |
2023年 | 221篇 |
2022年 | 573篇 |
2021年 | 933篇 |
2020年 | 567篇 |
2019年 | 774篇 |
2018年 | 709篇 |
2017年 | 499篇 |
2016年 | 711篇 |
2015年 | 1101篇 |
2014年 | 1288篇 |
2013年 | 1256篇 |
2012年 | 1541篇 |
2011年 | 1383篇 |
2010年 | 844篇 |
2009年 | 757篇 |
2008年 | 871篇 |
2007年 | 731篇 |
2006年 | 590篇 |
2005年 | 519篇 |
2004年 | 417篇 |
2003年 | 416篇 |
2002年 | 343篇 |
2001年 | 239篇 |
2000年 | 176篇 |
1999年 | 192篇 |
1998年 | 122篇 |
1997年 | 104篇 |
1996年 | 95篇 |
1995年 | 75篇 |
1994年 | 71篇 |
1993年 | 48篇 |
1992年 | 66篇 |
1991年 | 43篇 |
1990年 | 40篇 |
1989年 | 45篇 |
1988年 | 20篇 |
1987年 | 13篇 |
1986年 | 14篇 |
1985年 | 28篇 |
1984年 | 7篇 |
1983年 | 11篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1978年 | 1篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1966年 | 2篇 |
1961年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
981.
982.
Liangpeng Sun Peipei Wang Lili Xu Lixin Gao Jia Li Huri Piao 《Bioorganic & medicinal chemistry letters》2019,29(10):1187-1193
Two series of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups were identified as competitive protein tyrosine phosphatase 1B (PTP1B) inhibitors. Among the compounds studied, IIIv was found to have the best in vitro inhibition activity against PTP1B (IC50?=?0.67?±?0.09?µM) and the best selectivity (9-fold) between PTP1B and T-cell protein tyrosine phosphatase (TCPTP). Molecular docking studies demonstrated that compounds IIIm, IIIv and IVg could occupy simultaneously at both the catalytic site and the adjacent pTyr binding site. These results provide novel lead compounds for the design of inhibitors of PTP1B as well as other PTPs. 相似文献
983.
Ping Yu Wenjing Liu Jinghui Ren Yingying Wang Yao Ning Mingqi Huang Xinyi Hu Lili Wei Min Ji Jin Cai 《Bioorganic & medicinal chemistry letters》2019,29(16):2168-2172
Bromodomain-containing protein 4 (BRD4) is a new therapeutic target for the treatment of diseases including cardiovascular diseases, cancer, inflammation and central nervous system (CNS) disorders. In this study, we introduced the pharmacophore of fibrates to a BRD4 inhibitor, RVX-208, to design dual-active hypolipidemic compounds, and found that some of new analogues showed favorable hypolipidemic activities. Synthetic accessibility towards this class of compounds optimized RVX-208 as well as would supply more thoughts on hypolipidemic drugs. 相似文献
984.
Weiwei Li Jianjie Chu Tingting Fan Wei Zhang Minna Yao Zeqiong Ning Mingming Wang Jin Sun Xian Zhao Aidong Wen 《Bioorganic & medicinal chemistry letters》2019,29(14):1831-1835
In this investigation, a series of 1-phenyl-3-(5-(pyrimidin-4-ylthio)-1,3,4- thiadiazol-2-yl)urea receptor tyrosine kinase inhibitors were synthesized by a simple and efficient structure-based design. Structure-activity relationship (SAR) analysis of these compounds based on cellular assays led to the discovery of a number of compounds that showed potent activity against human chronic myeloid leukemia (CML) cell line K562, but very weak or no cellular toxicity through monitoring the growth kinetics of K562 cell during a period of 72 h using the real-time live-cell imaging. Among these compounds, 1-(5-((6-((3-morpholinopropyl) amino)pyrimidin-4-yl)thio)-1,3,4-thiadiazol-2-yl)-3-(4-(trifluoromethyl)phenyl)urea (7) exhibited the least cellular toxicity and better biological activity in cellular assays (K562, IC50: 0.038 μM). Compound 7 also displayed very good induced-apoptosis effect for human CML cell line K562 and exerted its effect via a significantly reduced protein phosphorylation of PI3K/Akt signal pathway by Human phospho-kinase array analysis. In vitro results indicate that 1-phenyl-3-(5-(pyrimidin-4-ylthio)-1,3,4- thiadiazol-2-yl)urea derivatives are lead molecules for further development as treatment of chronic myeloid leukemia and cancer. 相似文献
985.
Mammalian Genome - Increasing evidence shows that miRNAs play pivotal roles in cardiovascular diseases, including heart failure (HF). The aim of this study was to investigate the role of miR-129-5p... 相似文献
986.
987.
988.
989.
990.
Qian Chen Tian Sun Jin Wang James Jia Yan‐Hua Yi Yu‐Xin Chen Yong Miao Zhi‐Qi Hu 《Journal of biochemical and molecular toxicology》2019,33(9)
Hydroxytyrosol (HT), a primary phenolic antioxidant in olive oil, can afford protection from oxidative stress (OS) in different cells, including skin cells. In particular, it regulates several inflammation‐associated processes as well as in improving the antioxidant defense system. However, there is no information about HT used in the treatment of hair loss. This work aimed at exploring the potential protective actions of HT against OS in rat dermal papilla cells. After treatment, the related expression of protein and messenger RNA were detected using morphological and molecular analyses. The results showed that HT significantly reduced intracellular reactive oxygen species level, apoptotic markers and inflammation induced by OS and enhanced cell survival by regulating autophagy. Furthermore, HT enhanced the secretion of hair growth factors in the anti‐inflammation process. These results suggest that HT has a significant protective ability against OS and encourage the use of this biological ingredient as a possible tool to prevent alopecia. 相似文献